Related Experiment Video

Updated: May 3, 2026

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
07:04

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

18.9K

Methylprednisolone resistance of cystic fibrosis lymphocytes

E Langhoff, P S Pedersen, C Koch

    Pediatric Research
    |May 1, 1984
    PubMed

    Insights

    Lymphocytes from cystic fibrosis (CF) patients show normal sensitivity to methylprednisolone (MP), unlike CF skin fibroblasts which are resistant to dexamethasone. This study found no difference in MP response between CF and normal lymphocytes in vitro.

    Area of Science:

    • Immunology
    • Cell Biology
    • Genetics

    Background:

    • Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs.
    • CF skin fibroblasts exhibit increased resistance to dexamethasone.
    • Glucocorticoids have immunosuppressive effects.

    Purpose of the Study:

    • To investigate the in vitro response of lymphocytes from CF patients to methylprednisolone (MP).
    • To compare the sensitivity of CF lymphocytes to MP with that of normal lymphocytes.
    • To explore potential differences in cellular resistance to glucocorticoids in CF.

    Main Methods:

    • Lymphocyte cultures were prepared from patients with cystic fibrosis and normal controls.
    • Phytohemagglutinin (PHA) stimulation was used to activate lymphocytes.
    • Dose-response curves were generated to assess the effect of MP on lymphocyte proliferation.
    • Lymphocytes were exposed to MP via preincubation or pulse exposure.

    Main Results:

    • Methylprednisolone (MP) inhibited lymphocyte proliferation in a dose-dependent manner.
    • No significant difference was observed in the MP dose-response curves between CF and normal lymphocytes (P > 0.05).
    • Neither preincubation nor pulse exposure to MP revealed any differential effect on CF versus normal lymphocytes.

    Conclusions:

    • Lymphocytes from cystic fibrosis patients do not exhibit altered in vitro resistance to methylprednisolone.
    • The cellular response to methylprednisolone in lymphocytes differs from the reported dexamethasone resistance in CF fibroblasts.
    • Further research may be needed to understand glucocorticoid interactions in CF at the cellular level.

    More Related Videos

    Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD09:47

    Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD

    Published on: September 13, 2018

    19.7K
    Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study08:00

    Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

    Published on: April 11, 2018

    9.9K

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    2.6K
    Cystic Fibrosis: Pathogenesis01:23

    Cystic Fibrosis: Pathogenesis

    Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
    CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
    1.1K
    Cystic Fibrosis: Management01:24

    Cystic Fibrosis: Management

    Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
    Sinus disease and chronic...
    657
    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

    Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
    692